ARCHIVES

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

This article is from The Cancer Letter archive.

Vol. 15 No. 07 | February 17, 1989

Download PDF Visit The Full Archive

Related Articles

NCI Supports New Cervical Cancer Screening Guideline

January 31, 2003

Wyngaarden List, Reportedly Six-Seven Names For NCI Director, Goes to White House This Week

November 11, 1988

St. John’s Wort Not Indicated For Patients On Irinotecan

May 31, 2002

Clinical Practice Guidelines Don’t Meet IOM Standards

June 26, 2013

In Brief: Lobuglio Named Alabama Comprehensive Center Director; NCI FY 1983 Funds Will Be $983.6 Million

January 7, 1983

Group chairmen Advises 7 Trials For Priority Status

June 14, 1991